Javed Anees: The Essentials of aSAH Management
Javed Anees, Medical Consultant at Government of Kerala, shared a post on LinkedIn:
“Aneurysmal Subarachnoid Hemorrhage (aSAH) remains one of the most time-critical neurological emergencies, where every minute matters.
Early recognition of a thunderclap headache, prompt non-contrast CT, rapid CT angiography, timely aneurysm securing (coiling or clipping), and meticulous neurocritical care are the cornerstones of improving survival and functional outcomes.
Key evidence-based messages:
Secure the aneurysm early to prevent catastrophic rebleeding.
Nimodipine for 21 days remains the only pharmacological therapy consistently shown to improve neurological outcomes by reducing delayed cerebral ischemia.
Goal-directed euvolemia has replaced routine Triple-H therapy.
Continuous monitoring for vasospasm, hydrocephalus, electrolyte disturbances, cardiac dysfunction, and delayed cerebral ischemia is essential in the Neuro-ICU.
Successful management requires seamless collaboration between Emergency Medicine, Neurology, Neurosurgery, Neurointervention, Neurocritical Care, Radiology, and Rehabilitation.
I created this evidence-based educational infographic by integrating current recommendations from the 2023 AHA/ASA Guidelines, Neurocritical Care Society guidance, and landmark neurovascular studies to provide a practical, high-yield resource for clinicians and trainees.”
Other posts featuring Javed Anees on Hemostasis Today.
-
Jul 7, 2026, 14:06Christopher Robinson: Early Cytokine Signals in Amniotic Fluid Embolism
-
Jul 7, 2026, 14:06Mohamed Fouad Elsayed Khalil: Comprehensive Guidelines Evidence about Stroke Imaging in Pregnancy
-
Jul 7, 2026, 13:39Abuzar Ghaffari: A Proud ISBT Congress Milestone
-
Jul 7, 2026, 13:24Christoph B. Olivier: New DGK Consensus Recommendations on Switching Antiplatelet Therapies
-
Jul 7, 2026, 13:02Rucha Patil: Privilege to Speak at the West Bengal Hemophilia Conclave 2026 on HTA in Hemophilia Therapies
-
Jul 7, 2026, 06:19Simone Schoenwaelder: Women Are 25% More Likely to Have Their Stroke Misdiagnosed and Here’s Why
-
Jul 7, 2026, 06:12Dhiraj Bhatia: Extremely Happy to Share Our Review on DNA Nanotechnology in Stroke Repair
-
Jul 7, 2026, 06:04Brian A Beh: An Open Letter to Lisa Murphy Honouring the 30 Years of the Stroke Foundation’s Dedication
-
Jul 7, 2026, 05:55Alan Nurden: A Landmark Review Comparing Hemophilia and Hereditary Angioedema